Results 101 to 110 of about 2,862 (168)

Venous thromboembolic risk in hematological hospitalized patients: a retrospective study. [PDF]

Ann Hematol
Cordella S, Coluccio V, Cuoghi Costantini R, D'Amico R, Luppi M, Marietta M.   +5 more
europepmc   +1 more source

[Flagellate erythema secondary to bleomycin: case report with favorable outcome]. [PDF]

Rev Med Inst Mex Seguro Soc
Leal-León R, Tirado-Motel A, Escribano-Ponce M, González-Ruiz V, Vega-González MTJ.   +4 more
europepmc   +1 more source

[Radiological clinical profile of multiple cranial neuropathy and recurrence risk factors]. [PDF]

Rev Med Inst Mex Seguro Soc
Martínez-Vázquez A, García-Bermúdez RJ, Hernández-Domínguez JA, Sierra-Ramírez JA.   +3 more
europepmc   +1 more source

[Synchronous medullary and mucinous tumor in the right colon: case report] [PDF]

Rev Fac Cien Med Univ Nac Cordoba
Bastidas J, Posada H, Amante M, Pestalardo L, Muthular M, Stawkowy L, Petracchi E, Yazyi F.   +7 more
europepmc   +1 more source

[High glucose levels in children at diagnosis of acute lymphoblastic leukemia]. [PDF]

Rev Med Inst Mex Seguro Soc
Paque-Bautista C, Aranda-Romo SA, Medel-Sánchez A, González AP, Cerritos-García DE, Reyes-Sosa AM, Sosa-Bustamante GP.   +6 more
europepmc   +1 more source

Mismatch Between Preclinical Cardio-Oncology and Clinical Oncology Research. [PDF]

JACC CardioOncol
Cagnazzo R, Stabile M, Zoppoli G, De Boer RA, Meijers WC, van Der Meer P, Ameri P.   +6 more
europepmc   +1 more source

First report of indolent cutaneous T-cell lymphoma in a fennec fox (Vulpes zerda). [PDF]

Vet Dermatol
Shekelle KL, Glassman AR, Backues KA, Kilburn JJ, Foust-Wheatcraft DA, Stranahan LW.   +5 more
europepmc   +1 more source

Early progression beyond first-line chemoimmunotherapy in follicular lymphoma: Insights from a Fondazione Italiana Linfoma (FIL) study. [PDF]

Hemasphere
Bavieri A, Nizzoli ME, Tucci A, Zilioli VR, Olivieri J, Bianchi B, Rosaria MG, Annibali O, Bari A, Casaluci GM, Cimminiello M, Di Renzo N, Cavallo F, Pavone V, Mannarella C, Arcari A, Alessandro M, Anastasia A, Tarantino V, Neri A, Gentile M, Morabito F, Luminari S.   +22 more
europepmc   +1 more source

Analisi di costo-efficacia di brentuximab vedotin in combinazione con doxorubicina, vinblastina e dacarbazina (AVD) in pazienti adulti affetti da linfoma di Hodgkin in stadio IV. [PDF]

Glob Reg Health Technol Assess
Marcellusi A, Bini C, Mennini FS, Ripoli S, Fioravanti L, Paly VF, Molinari AL, Morelli P, Krotneva S, Li S.   +9 more
europepmc   +1 more source